Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Debt / NOTE 1.000%11/1
-
Market price (% of par)
-
105.88%
-
Total 13F principal
-
$591,689,000
-
Principal change
-
+$25,692,690
-
Total reported market value
-
$627,229,697
-
Number of holders
-
42
-
Value change
-
+$26,831,916
-
Number of buys
-
22
-
Number of sells
-
14
Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q3 2017
As of 30 Sep 2017,
ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 was held by
42 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$591,689,000
in principal (par value) of the bond.
The largest 10 bondholders included
WOLVERINE ASSET MANAGEMENT LLC, Allianz Asset Management GmbH, DEERFIELD MANAGEMENT CO, CNH PARTNERS LLC, ADVENT CAPITAL MANAGEMENT /DE/, Linden Advisors LP, CITADEL ADVISORS LLC, OAKTREE CAPITAL MANAGEMENT LP, MACKAY SHIELDS LLC, and TENOR CAPITAL MANAGEMENT Co., L.P..
This page lists
42
institutional bondholders reporting positions
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.